Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

189 evidences · page 3 / 8

25 %Malaria parasitemia prevalence was 25% among people living with HIV in the rural area of Atibie, Ghana.

Ghanapaludismepublié 2018Acta tropicaPubMeddocument de 4 observations

43 %Dans l’étude SIREN, 43 % des patients avaient le diabète.

Ghana · Nigerdiabète (non précisé)observé 28 août 2014–15 juin 2017HAL · Unilimdocument de 570 observations

3,46 ORA family history of diabetes was associated with an odds ratio of 3.46 for diabetes among adult Ghanaians.

Ghanadiabète (non précisé)publié 2019International healtheurope_pmcdocument de 4 observations

2,6 %A mixed lung function pattern was observed in 2.6% (n = 3) of children with sickle cell disease compared to 0% in controls.

GhanadrépanocytosePubMeddocument de 6 observations

65 %In the Philippines, 65% of dengue patients were hospitalized and constituted 90% of direct costs.

GhanadengueHAL · Unilimdocument de 40 observations

1,7 %The HIV prevalence rate is 1.7% in Ghana.

GhanaVIH/sidaHAL · Unilimdocument de 97 observations

2 450 cases_averted_per_1000_childrenIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 children vaccinated at month 32 post-dose 1, was 2450 for group R012-14-26.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

42 %The overall prevalence of schoolchildren with any skin disease was 42.0% in another Ghanaian study.

Ghanaskin diseasepublié 2013International journal of dermatologyeurope_pmcdocument de 8 observations

60 individualsIn the study by Asante et al. (2020), 60 adults with type 2 diabetes mellitus were enrolled in Ghana.

Ghanadiabète de type 2observé 2020HAL · Unilimdocument de 50 observations

47,9 %In Ghana, malaria prevalence among pregnant women at first antenatal care visit was 47.9% (622 of 1298).

Ghanapaludismeobservé between May, 2010, and August, 2014PubMeddocument de 8 observations

0,03 %The National Dengue Vector Control Programme in Malaysia cost 0.03% of Gross Domestic Product (GDP), from 2007 to 2012.

Ghanadengueobservé 2007 to 2012HAL · Unilimdocument de 40 observations

-0,8 z-scoreChildren with sickle cell disease had significantly lower mean z-scores for forced vital capacity (FVC) compared to controls: -0.8 (SD 1.2) versus -0.3 (SD 1.3), p < 0.001.

GhanadrépanocytosePubMeddocument de 6 observations

874 cases_averted_per_1000_full_dose_equivalentsIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 RTS,S full-dose equivalents at month 32 post-dose 1, was 874 for group Fx012-14-26.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

29,95 DALYsEach case of microcephaly due to Zika virus infection results in a loss of 29.95 Disability-Adjusted Life Years (DALYs).

GhanamicrocephalyHAL · Unilimdocument de 40 observations

96,1 %96.1% of enrolled patients met protocol requirements for analysis in an observational study on dihydroartemisinin-piperaquine for uncomplicated malaria in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

0,5 fraction_of_populationOne half of the world's population is now at risk of dengue.

GhanadengueHAL · Unilimdocument de 40 observations

4,4 %The period-prevalence of eczema was 4.4% in another Ghanaian study.

Ghanaeczemapublié 2012Journal of the European Academy of Dermatology and Venereology : JEADVeurope_pmcdocument de 10 observations

19,6 %La fréquence hospitalière de la neuropathie périphérique rapportée dans une étude hospitalière menée en 2021 au Ghana était de 19,6 %.

Ghananeuropathie périphériqueobservé 2021HAL · Unilimdocument de 747 observations

Ghana, Kenya, and Malawi were the first countries to introduce the RTS,S/AS01 malaria vaccine into their childhood immunization programmes in 2019 as part of a pilot programme called the Malaria Vaccine Implementation Programme (MVIP).

Ghana · Kenya · Malawipaludismeobservé 2019publié 2025Malaria journalPubMeddocument de 2 observations

Obesity prevalence among Ghanaian migrants and Ghanaians living in Ghana is presented as age-standardised prevalence of obesity (BMI ≥30 kg/m2) by locality in men and women.

GhanaobésitéHAL · Unilimdocument de 3 observations

2 casesMethicillin-resistant S. aureus (n = 2) were detected in Ghana only.

Ghanamethicillin-resistant S. aureusobservé November 2013 to March 2017publié 2020Frontiers in microbiologyeurope_pmcdocument de 12 observations

6,46 %The overall prevalence of diabetes mellitus among adult Ghanaians was 6.46% based on the inverse-variance random-effects model.

Ghanadiabète (non précisé)publié 2019International healtheurope_pmcdocument de 4 observations

99,5 %Nearly all the participants had sensorineural hearing impairment (99.5%; n = 639).

Ghanasensorineural hearing impairmentpublié 2019Frontiers in geneticseurope_pmcdocument de 10 observations

In the study by Asante et al. (2020), mean HbA1c levels at 12 weeks were significantly lower in the intervention group (p = 0.004).

Ghanadiabète de type 2observé 2020HAL · Unilimdocument de 50 observations

46 samplesA total of 46 RSV-positive samples were identified among febrile children with acute respiratory tract infection across Ghana, Gabon, Tanzania, and Burkina Faso between 2014 and 2017.

Burkina Faso · Gabon · Ghana · Tanzanierespiratory syncytial virus (RSV)observé 2014 and 2017publié 2021Tropical medicine & international health : TM & IHeurope_pmcdocument de 5 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.